United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/04/21
United Therapeutics (UTHR) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/04/21
United Therapeutics Corporation To Present At The 2021 Wedbush PacGrow Healthcare Virtual ConferencePRNewsWire • 08/03/21
United Therapeutics (UTHR) to Report Q2 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 07/28/21
United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021PRNewsWire • 07/28/21
United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE StudyPRNewsWire • 06/30/21
MannKind And United Therapeutics Achieve A Major Milestone In The Development Of Tyvaso DPI™ With New Drug Application Acceptance From The FDAPRNewsWire • 06/16/21
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority ReviewPRNewsWire • 06/16/21
United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against LiquidiaPRNewsWire • 06/07/21
Why Is United Therapeutics (UTHR) Down 8.8% Since Last Earnings Report?Zacks Investment Research • 06/04/21
United Therapeutics Announces First Patient Enrolled In Phase 3 TETON Study Of Tyvaso In Patients With Idiopathic Pulmonary FibrosisPRNewsWire • 06/03/21
United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare ConferencePRNewsWire • 05/25/21
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/05/21
United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021PRNewsWire • 04/26/21